Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma

被引：0
|
作者：
Hewen Shi
Ying Zou
Xiaoxue Wang
Guoli Wang
Yijia Gao
Fan Yi
junqing Xu
Yancun Yin
Defang Li
Minjing Li
机构：
[1] Binzhou Medical University,Featured Laboratory for Biosynthesis and Target Discovery of Active Components of Traditional Chinese Medicine, School of Integrated Traditional Chinese and Western Medicine
[2] Binzhou Medical University,School of Basic Medical Sciences
[3] Qingdao University Medical College,Department of Hematology
[4] Affiliated Yantai Yuhuangding Hoepital,undefined
来源：
Discover Oncology | / 14卷
关键词：
Hippo pathway; Nevadensin; YAP; Sensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
    Xin Zhou
    Jianzhu Luo
    Haixiang Xie
    Zhongliu Wei
    Tianman Li
    Junqi Liu
    Xiwen Liao
    Guangzhi Zhu
    Tao Peng
    Cell Death Discovery, 8
  • [42] Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma
    Suk, Fat-Moon
    Liu, Chao-Lien
    Hsu, Ming-Hua
    Chuang, Yu-Ting
    Wang, Jack P.
    Liao, Yi-Jen
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [43] Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
    Zhao, Dali
    Zhai, Bo
    He, Changjun
    Tan, Gang
    Jiang, Xian
    Pan, Shangha
    Dong, Xuesong
    Wei, Zheng
    Ma, Lixin
    Qiao, Haiquan
    Jiang, Hongchi
    Sun, Xueying
    CELLULAR SIGNALLING, 2014, 26 (05) : 1030 - 1039
  • [44] Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma
    Fat-Moon Suk
    Chao-Lien Liu
    Ming-Hua Hsu
    Yu-Ting Chuang
    Jack P. Wang
    Yi-Jen Liao
    Scientific Reports, 9
  • [45] Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma
    Shi, Hewen
    Zou, Ying
    Zhong, Weiwei
    Li, Zhaoying
    Wang, Xiaoxue
    Yin, Yancun
    Li, Defang
    Liu, Ying
    Li, Minjing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (16) : 15311 - 15322
  • [46] Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma
    Hewen Shi
    Ying Zou
    Weiwei Zhong
    Zhaoying Li
    Xiaoxue Wang
    Yancun Yin
    Defang Li
    Ying Liu
    Minjing Li
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 15311 - 15322
  • [47] High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
    Moon, Hyuk
    Cho, Kyungjoo
    Shin, Sunyeong
    Kim, Do Young
    Han, Kwang-Hyub
    Ro, Simon Weonsang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [48] Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review)
    Li, Shenghao
    Hao, Liyuan
    Li, Na
    Hu, Xiaoyu
    Yan, Huimin
    Dai, Erhei
    Shi, Xinli
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2024, 65 (03)
  • [49] Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway
    Li, Jianchun
    Wang, Honglian
    Wang, Lu
    Tan, Ruizhi
    Zhu, Menglian
    Zhong, Xia
    Zhang, Yuwei
    Chen, Bo
    Wang, Li
    PHYTOTHERAPY RESEARCH, 2018, 32 (12) : 2456 - 2465
  • [50] PCK1 attenuates tumor stemness via activating the Hippo signaling pathway in hepatocellular carcinoma
    Liu, Rui
    Liu, Yi
    Zhang, Wenlu
    Zhang, Guiji
    Zhang, Zhirong
    Huang, Luyi
    Tang, Ni
    Wang, Kai
    GENES & DISEASES, 2024, 11 (04)
12345